landiolol

FDA Drug Profile — RAPIBLYK

Drug Details

Generic Name
landiolol
Brand Names
RAPIBLYK
Application Number
NDA217202
Sponsor
AOP Health US, LLC
NDC Codes
2
Dosage Forms
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients
LANDIOLOL HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE RAPIBLYK is indicated for the short-term reduction of ventricular rate in adults with supraventricular tachycardia including atrial fibrillation and atrial flutter. RAPIBLYK is a beta adrenergic blocker indicated for the short-term reduction of ventricular rate in adults with supraventricular tachycardia including atrial fibrillation and atrial flutter. ( 1 )